Structure

Physi-Chem Properties

Molecular Weight:  120.06
Volume:  136.612
LogP:  1.155
LogD:  1.296
LogS:  -1.009
# Rotatable Bonds:  2
TPSA:  17.07
# H-Bond Aceptor:  1
# H-Bond Donor:  0
# Rings:  1
# Heavy Atoms:  1

MedChem Properties

QED Drug-Likeness Score:  0.539
Synthetic Accessibility Score:  1.706
Fsp3:  0.125
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Accepted
BMS Rule:  1
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.291
MDCK Permeability:  3.267739521106705e-05
Pgp-inhibitor:  0.0
Pgp-substrate:  0.007
Human Intestinal Absorption (HIA):  0.005
20% Bioavailability (F20%):  0.056
30% Bioavailability (F30%):  0.002

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.933
Plasma Protein Binding (PPB):  36.94427490234375%
Volume Distribution (VD):  1.575
Pgp-substrate:  67.031982421875%

ADMET: Metabolism

CYP1A2-inhibitor:  0.699
CYP1A2-substrate:  0.448
CYP2C19-inhibitor:  0.225
CYP2C19-substrate:  0.3
CYP2C9-inhibitor:  0.024
CYP2C9-substrate:  0.115
CYP2D6-inhibitor:  0.157
CYP2D6-substrate:  0.479
CYP3A4-inhibitor:  0.018
CYP3A4-substrate:  0.251

ADMET: Excretion

Clearance (CL):  9.592
Half-life (T1/2):  0.784

ADMET: Toxicity

hERG Blockers:  0.097
Human Hepatotoxicity (H-HT):  0.059
Drug-inuced Liver Injury (DILI):  0.313
AMES Toxicity:  0.395
Rat Oral Acute Toxicity:  0.019
Maximum Recommended Daily Dose:  0.03
Skin Sensitization:  0.957
Carcinogencity:  0.319
Eye Corrosion:  0.973
Eye Irritation:  0.992
Respiratory Toxicity:  0.952

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC208069

Natural Product ID:  NPC208069
Common Name*:   Pestalofone E
IUPAC Name:   methyl 8-hydroxy-3-methoxy-6-methyl-9-oxo-7-(2-oxopropyl)-5-[2-oxo-2-[(1S,2S,4R,5R,6R)-2,4,5-trihydroxy-6-(3-methylbut-2-enyl)-7-oxabicyclo[4.1.0]heptan-4-yl]ethyl]xanthene-1-carboxylate
Synonyms:   Pestalofone E
Standard InCHIKey:  FYULFHVQQBWSCF-JRLFQTPXSA-N
Standard InCHI:  InChI=1S/C33H36O12/c1-14(2)7-8-33-29(45-33)21(35)13-32(41,31(33)40)23(36)12-19-16(4)18(9-15(3)34)26(37)25-27(38)24-20(30(39)43-6)10-17(42-5)11-22(24)44-28(19)25/h7,10-11,21,29,31,35,37,40-41H,8-9,12-13H2,1-6H3/t21-,29-,31+,32-,33-/m0/s1
SMILES:  COC(=O)c1cc(OC)cc2c1c(=O)c1c(o2)c(CC(=O)[C@@]2(O)C[C@H](O)[C@H]3[C@]([C@@H]2O)(CC=C(C)C)O3)c(c(c1O)CC(=O)C)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL443191
PubChem CID:   42609855
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000002] Organoheterocyclic compounds
      • [CHEMONTID:0000123] Benzopyrans
        • [CHEMONTID:0003410] 1-benzopyrans
          • [CHEMONTID:0002817] Dibenzopyrans
            • [CHEMONTID:0000200] Xanthenes
              • [CHEMONTID:0000204] Xanthones
                • [CHEMONTID:0003518] 4-prenylated xanthones

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO22690 Pestalotiopsis fici Species Sporocadaceae Eukaryota n.a. n.a. n.a. PMID[18468908]
NPO22690 Pestalotiopsis fici Species Sporocadaceae Eukaryota n.a. n.a. n.a. PMID[19101157]
NPO22690 Pestalotiopsis fici Species Sporocadaceae Eukaryota n.a. n.a. n.a. PMID[19618920]
NPO22690 Pestalotiopsis fici Species Sporocadaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT1452 Cell Line C8166 Homo sapiens CC50 > 200000.0 nM PMID[525559]
NPT24 Organism Human immunodeficiency virus 1 Human immunodeficiency virus 1 EC50 = 93700.0 nM PMID[525559]
NPT87 Organism Aspergillus fumigatus Aspergillus fumigatus IC50 = 900.0 nM PMID[525559]
NPT87 Organism Aspergillus fumigatus Aspergillus fumigatus MIC = 31200.0 nM PMID[525559]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC208069 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9222 High Similarity NPC472049
0.9205 High Similarity NPC314672
0.9186 High Similarity NPC477683
0.9186 High Similarity NPC477682
0.9181 High Similarity NPC68381
0.9138 High Similarity NPC475148
0.9138 High Similarity NPC475656
0.9112 High Similarity NPC76647
0.908 High Similarity NPC475161
0.908 High Similarity NPC477860
0.9064 High Similarity NPC473113
0.9064 High Similarity NPC111536
0.9064 High Similarity NPC271385
0.9064 High Similarity NPC5029
0.9064 High Similarity NPC30432
0.9064 High Similarity NPC76128
0.9029 High Similarity NPC313452
0.9017 High Similarity NPC46958
0.9017 High Similarity NPC475233
0.9012 High Similarity NPC472054
0.9012 High Similarity NPC476311
0.9006 High Similarity NPC298778
0.9 High Similarity NPC225419
0.9 High Similarity NPC473094
0.8982 High Similarity NPC472055
0.8971 High Similarity NPC315221
0.896 High Similarity NPC294149
0.8953 High Similarity NPC158226
0.8947 High Similarity NPC473096
0.8947 High Similarity NPC473095
0.8947 High Similarity NPC99613
0.8947 High Similarity NPC49487
0.8944 High Similarity NPC314020
0.8935 High Similarity NPC474240
0.8927 High Similarity NPC197972
0.8922 High Similarity NPC470339
0.8914 High Similarity NPC212290
0.8908 High Similarity NPC469345
0.8908 High Similarity NPC312630
0.8908 High Similarity NPC324220
0.8908 High Similarity NPC475246
0.8902 High Similarity NPC154986
0.8902 High Similarity NPC98776
0.8895 High Similarity NPC241874
0.8889 High Similarity NPC472622
0.8889 High Similarity NPC474024
0.8882 High Similarity NPC475888
0.8876 High Similarity NPC105591
0.8876 High Similarity NPC211107
0.8869 High Similarity NPC470810
0.8857 High Similarity NPC207467
0.8857 High Similarity NPC476210
0.8857 High Similarity NPC476199
0.8851 High Similarity NPC474345
0.8851 High Similarity NPC3718
0.8851 High Similarity NPC232412
0.8851 High Similarity NPC199533
0.8851 High Similarity NPC86809
0.8851 High Similarity NPC98667
0.8851 High Similarity NPC470454
0.8851 High Similarity NPC146803
0.8844 High Similarity NPC472620
0.8844 High Similarity NPC477836
0.8837 High Similarity NPC102810
0.8837 High Similarity NPC222455
0.8837 High Similarity NPC163130
0.8837 High Similarity NPC165979
0.8833 High Similarity NPC48474
0.883 High Similarity NPC207575
0.883 High Similarity NPC29160
0.883 High Similarity NPC125465
0.883 High Similarity NPC13481
0.883 High Similarity NPC472621
0.882 High Similarity NPC112380
0.882 High Similarity NPC87583
0.8817 High Similarity NPC117985
0.8817 High Similarity NPC3629
0.8817 High Similarity NPC474239
0.8814 High Similarity NPC475662
0.8814 High Similarity NPC473717
0.8814 High Similarity NPC473631
0.8814 High Similarity NPC293227
0.8807 High Similarity NPC473785
0.8807 High Similarity NPC473729
0.8807 High Similarity NPC277710
0.8807 High Similarity NPC114257
0.8807 High Similarity NPC84494
0.8807 High Similarity NPC153578
0.8807 High Similarity NPC245059
0.8807 High Similarity NPC299149
0.8802 High Similarity NPC164427
0.8793 High Similarity NPC469393
0.8791 High Similarity NPC314687
0.8791 High Similarity NPC470198
0.8791 High Similarity NPC470193
0.8791 High Similarity NPC470196
0.8791 High Similarity NPC470194
0.8791 High Similarity NPC470197
0.8791 High Similarity NPC470200
0.8791 High Similarity NPC316274
0.8791 High Similarity NPC470195
0.8791 High Similarity NPC282474
0.8786 High Similarity NPC251144
0.8786 High Similarity NPC313717
0.8786 High Similarity NPC241387
0.8786 High Similarity NPC315306
0.8786 High Similarity NPC313304
0.8779 High Similarity NPC218226
0.8779 High Similarity NPC324522
0.8779 High Similarity NPC470341
0.8779 High Similarity NPC150131
0.8779 High Similarity NPC6588
0.8779 High Similarity NPC234331
0.8779 High Similarity NPC477154
0.8779 High Similarity NPC472058
0.8779 High Similarity NPC107009
0.8779 High Similarity NPC105414
0.8779 High Similarity NPC234497
0.8779 High Similarity NPC117854
0.8772 High Similarity NPC471788
0.8765 High Similarity NPC478229
0.8765 High Similarity NPC473961
0.8757 High Similarity NPC470448
0.8757 High Similarity NPC470452
0.8757 High Similarity NPC284495
0.8757 High Similarity NPC471976
0.8757 High Similarity NPC470453
0.8757 High Similarity NPC164047
0.875 High Similarity NPC131405
0.875 High Similarity NPC281137
0.875 High Similarity NPC282390
0.8743 High Similarity NPC175192
0.8743 High Similarity NPC162248
0.8743 High Similarity NPC99381
0.8743 High Similarity NPC68727
0.8743 High Similarity NPC245975
0.8743 High Similarity NPC326910
0.8743 High Similarity NPC63105
0.8736 High Similarity NPC271848
0.8736 High Similarity NPC81332
0.8736 High Similarity NPC262580
0.8736 High Similarity NPC212038
0.8736 High Similarity NPC289396
0.8736 High Similarity NPC121333
0.8735 High Similarity NPC154683
0.8735 High Similarity NPC40356
0.8735 High Similarity NPC321363
0.8735 High Similarity NPC253904
0.8728 High Similarity NPC326877
0.8728 High Similarity NPC472619
0.8728 High Similarity NPC259905
0.8721 High Similarity NPC471823
0.8721 High Similarity NPC178173
0.8721 High Similarity NPC477835
0.8721 High Similarity NPC178851
0.8721 High Similarity NPC471213
0.8721 High Similarity NPC43319
0.8715 High Similarity NPC229817
0.8715 High Similarity NPC475352
0.8715 High Similarity NPC221140
0.8715 High Similarity NPC473686
0.8715 High Similarity NPC475220
0.8713 High Similarity NPC474350
0.8713 High Similarity NPC236132
0.8713 High Similarity NPC7483
0.8713 High Similarity NPC41301
0.8713 High Similarity NPC197168
0.8706 High Similarity NPC474186
0.8706 High Similarity NPC474351
0.8706 High Similarity NPC475883
0.8706 High Similarity NPC478222
0.8701 High Similarity NPC473607
0.8701 High Similarity NPC113446
0.8698 High Similarity NPC85121
0.869 High Similarity NPC215917
0.869 High Similarity NPC208152
0.869 High Similarity NPC471787
0.869 High Similarity NPC472050
0.869 High Similarity NPC20530
0.869 High Similarity NPC10754
0.869 High Similarity NPC78492
0.869 High Similarity NPC146211
0.8686 High Similarity NPC476374
0.8686 High Similarity NPC199357
0.8686 High Similarity NPC213052
0.8683 High Similarity NPC293286
0.8683 High Similarity NPC100134
0.8683 High Similarity NPC469405
0.8683 High Similarity NPC209760
0.8681 High Similarity NPC314459
0.8681 High Similarity NPC470199
0.8678 High Similarity NPC193698
0.8678 High Similarity NPC74559
0.8678 High Similarity NPC124470
0.8678 High Similarity NPC109827
0.8675 High Similarity NPC470569
0.8675 High Similarity NPC478148
0.8674 High Similarity NPC295436
0.8671 High Similarity NPC158761
0.8671 High Similarity NPC249977

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC208069 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8876 High Similarity NPD7879 Clinical (unspecified phase)
0.875 High Similarity NPD7075 Discontinued
0.8683 High Similarity NPD7819 Suspended
0.8621 High Similarity NPD5844 Phase 1
0.8613 High Similarity NPD7473 Discontinued
0.8571 High Similarity NPD7096 Clinical (unspecified phase)
0.8547 High Similarity NPD6232 Discontinued
0.8488 Intermediate Similarity NPD6959 Discontinued
0.8471 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.8448 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.8448 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.8448 Intermediate Similarity NPD6166 Phase 2
0.8444 Intermediate Similarity NPD8150 Discontinued
0.8418 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.8409 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.8402 Intermediate Similarity NPD6801 Discontinued
0.8393 Intermediate Similarity NPD4380 Phase 2
0.8353 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.8352 Intermediate Similarity NPD3751 Discontinued
0.8324 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.8307 Intermediate Similarity NPD7435 Discontinued
0.8304 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.8304 Intermediate Similarity NPD5402 Approved
0.8278 Intermediate Similarity NPD8312 Approved
0.8278 Intermediate Similarity NPD8313 Approved
0.8235 Intermediate Similarity NPD7411 Suspended
0.8222 Intermediate Similarity NPD7808 Phase 3
0.8208 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.8198 Intermediate Similarity NPD3817 Phase 2
0.8187 Intermediate Similarity NPD1934 Approved
0.8187 Intermediate Similarity NPD8151 Discontinued
0.8176 Intermediate Similarity NPD6599 Discontinued
0.8167 Intermediate Similarity NPD7251 Discontinued
0.8167 Intermediate Similarity NPD6559 Discontinued
0.8156 Intermediate Similarity NPD7074 Phase 3
0.8152 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.8148 Intermediate Similarity NPD6779 Approved
0.8148 Intermediate Similarity NPD6776 Approved
0.8148 Intermediate Similarity NPD6778 Approved
0.8148 Intermediate Similarity NPD6780 Approved
0.8148 Intermediate Similarity NPD6777 Approved
0.8148 Intermediate Similarity NPD6781 Approved
0.8148 Intermediate Similarity NPD6782 Approved
0.8144 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.8144 Intermediate Similarity NPD7874 Approved
0.8142 Intermediate Similarity NPD8434 Phase 2
0.8136 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.8125 Intermediate Similarity NPD3787 Discontinued
0.8118 Intermediate Similarity NPD3226 Approved
0.8115 Intermediate Similarity NPD7698 Approved
0.8115 Intermediate Similarity NPD7697 Approved
0.8115 Intermediate Similarity NPD7696 Phase 3
0.8114 Intermediate Similarity NPD5494 Approved
0.8111 Intermediate Similarity NPD6797 Phase 2
0.8101 Intermediate Similarity NPD7054 Approved
0.8095 Intermediate Similarity NPD2534 Approved
0.8095 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.8095 Intermediate Similarity NPD2533 Approved
0.8095 Intermediate Similarity NPD2532 Approved
0.8087 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.8073 Intermediate Similarity NPD7871 Phase 2
0.8073 Intermediate Similarity NPD7870 Phase 2
0.8056 Intermediate Similarity NPD7472 Approved
0.8046 Intermediate Similarity NPD3882 Suspended
0.8046 Intermediate Similarity NPD7768 Phase 2
0.8045 Intermediate Similarity NPD3818 Discontinued
0.8041 Intermediate Similarity NPD7701 Phase 2
0.8036 Intermediate Similarity NPD6799 Approved
0.8035 Intermediate Similarity NPD2801 Approved
0.8035 Intermediate Similarity NPD1465 Phase 2
0.8 Intermediate Similarity NPD5403 Approved
0.8 Intermediate Similarity NPD3749 Approved
0.7988 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7947 Intermediate Similarity NPD7699 Phase 2
0.7947 Intermediate Similarity NPD7700 Phase 2
0.7919 Intermediate Similarity NPD7783 Phase 2
0.7919 Intermediate Similarity NPD7801 Approved
0.7919 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7887 Intermediate Similarity NPD8320 Phase 1
0.7887 Intermediate Similarity NPD8319 Approved
0.7884 Intermediate Similarity NPD6535 Approved
0.7884 Intermediate Similarity NPD6534 Approved
0.7882 Intermediate Similarity NPD5401 Approved
0.7844 Intermediate Similarity NPD1549 Phase 2
0.7836 Intermediate Similarity NPD1512 Approved
0.7801 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7784 Intermediate Similarity NPD2346 Discontinued
0.7784 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7784 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7771 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7751 Intermediate Similarity NPD4628 Phase 3
0.7751 Intermediate Similarity NPD3750 Approved
0.7747 Intermediate Similarity NPD7228 Approved
0.7745 Intermediate Similarity NPD8155 Clinical (unspecified phase)
0.7738 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.772 Intermediate Similarity NPD8285 Discontinued
0.7719 Intermediate Similarity NPD1511 Approved
0.7701 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7692 Intermediate Similarity NPD6823 Phase 2
0.767 Intermediate Similarity NPD37 Approved
0.7654 Intermediate Similarity NPD6234 Discontinued
0.7647 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.764 Intermediate Similarity NPD4967 Phase 2
0.764 Intermediate Similarity NPD4965 Approved
0.764 Intermediate Similarity NPD4966 Approved
0.7624 Intermediate Similarity NPD5710 Approved
0.7624 Intermediate Similarity NPD5711 Approved
0.7619 Intermediate Similarity NPD2935 Discontinued
0.7619 Intermediate Similarity NPD2796 Approved
0.7616 Intermediate Similarity NPD7390 Discontinued
0.7602 Intermediate Similarity NPD6190 Approved
0.7588 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7581 Intermediate Similarity NPD7685 Pre-registration
0.756 Intermediate Similarity NPD1510 Phase 2
0.7556 Intermediate Similarity NPD919 Approved
0.7545 Intermediate Similarity NPD1607 Approved
0.7527 Intermediate Similarity NPD5953 Discontinued
0.7515 Intermediate Similarity NPD6099 Approved
0.7515 Intermediate Similarity NPD1551 Phase 2
0.7515 Intermediate Similarity NPD6100 Approved
0.7487 Intermediate Similarity NPD7211 Clinical (unspecified phase)
0.7486 Intermediate Similarity NPD3926 Phase 2
0.7486 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7473 Intermediate Similarity NPD7199 Phase 2
0.7473 Intermediate Similarity NPD1247 Approved
0.7471 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7456 Intermediate Similarity NPD3748 Approved
0.743 Intermediate Similarity NPD8455 Phase 2
0.7425 Intermediate Similarity NPD1240 Approved
0.7419 Intermediate Similarity NPD7286 Phase 2
0.7411 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7401 Intermediate Similarity NPD7458 Discontinued
0.7394 Intermediate Similarity NPD7240 Approved
0.7386 Intermediate Similarity NPD920 Approved
0.7384 Intermediate Similarity NPD2800 Approved
0.7371 Intermediate Similarity NPD6212 Phase 3
0.7371 Intermediate Similarity NPD6214 Clinical (unspecified phase)
0.7371 Intermediate Similarity NPD6213 Phase 3
0.7353 Intermediate Similarity NPD2799 Discontinued
0.7341 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7337 Intermediate Similarity NPD7229 Phase 3
0.731 Intermediate Similarity NPD5408 Approved
0.731 Intermediate Similarity NPD5404 Approved
0.731 Intermediate Similarity NPD5405 Approved
0.731 Intermediate Similarity NPD5406 Approved
0.7305 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7288 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7283 Intermediate Similarity NPD8127 Discontinued
0.7283 Intermediate Similarity NPD1243 Approved
0.7278 Intermediate Similarity NPD230 Phase 1
0.7277 Intermediate Similarity NPD7584 Approved
0.7273 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7273 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7232 Intermediate Similarity NPD6273 Approved
0.723 Intermediate Similarity NPD8059 Phase 3
0.723 Intermediate Similarity NPD8058 Clinical (unspecified phase)
0.7222 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7219 Intermediate Similarity NPD4060 Phase 1
0.7202 Intermediate Similarity NPD2313 Discontinued
0.7198 Intermediate Similarity NPD7930 Approved
0.7181 Intermediate Similarity NPD7893 Clinical (unspecified phase)
0.7181 Intermediate Similarity NPD7177 Discontinued
0.7174 Intermediate Similarity NPD5537 Clinical (unspecified phase)
0.7166 Intermediate Similarity NPD7784 Clinical (unspecified phase)
0.7159 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7156 Intermediate Similarity NPD8366 Approved
0.7151 Intermediate Similarity NPD1653 Approved
0.7151 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD4625 Phase 3
0.7143 Intermediate Similarity NPD7003 Approved
0.7135 Intermediate Similarity NPD6651 Approved
0.7129 Intermediate Similarity NPD8404 Phase 2
0.7128 Intermediate Similarity NPD4287 Approved
0.7118 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7118 Intermediate Similarity NPD1613 Approved
0.7118 Intermediate Similarity NPD943 Approved
0.7101 Intermediate Similarity NPD6798 Discontinued
0.7101 Intermediate Similarity NPD7985 Registered
0.7101 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7086 Intermediate Similarity NPD6674 Discontinued
0.7083 Intermediate Similarity NPD6832 Phase 2
0.7083 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7076 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7076 Intermediate Similarity NPD447 Suspended
0.7076 Intermediate Similarity NPD6355 Discontinued
0.7076 Intermediate Similarity NPD5124 Phase 1
0.7075 Intermediate Similarity NPD7907 Approved
0.7073 Intermediate Similarity NPD7585 Approved
0.7071 Intermediate Similarity NPD4363 Phase 3
0.7071 Intermediate Similarity NPD4360 Phase 2
0.7069 Intermediate Similarity NPD2344 Approved
0.7059 Intermediate Similarity NPD6233 Phase 2
0.7052 Intermediate Similarity NPD7033 Discontinued
0.7051 Intermediate Similarity NPD8067 Phase 3
0.7049 Intermediate Similarity NPD5761 Phase 2
0.7049 Intermediate Similarity NPD5760 Phase 2
0.7045 Intermediate Similarity NPD7982 Clinical (unspecified phase)
0.7041 Intermediate Similarity NPD8360 Approved
0.7041 Intermediate Similarity NPD8361 Approved
0.7024 Intermediate Similarity NPD7583 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data